Everpure's John Colgrove gifts 100,000 shares
The trust's share sales were made under a Rule 10b5-1 trading plan adopted January 8, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Everpure, Inc. (P) Chief Visionary Officer and director John Colgrove reported a 100,000-share gift of Class A common stock to The Colgrove Family Charitable Remainder Trust on October 14, 2026; his direct holdings after the gift were 5,393,309 shares. The trust separately sold 100,000 shares that day at reported prices of $141.31 to $153.68 per share. Those sales were made under a Rule 10b5-1 trading plan adopted on January 8, 2026, on behalf of the trust.
Insights
Analyzing...
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Class A Common Stock F1 | 100,000 | $0.00 | $0.00 |
| Gift | Class A Common Stock F1, F2 | 100,000 | $0.00 | $0.00 |
| Sale | Class A Common Stock F3, F4, F2 | 21,965 | $141.31 | $3.10M |
| Sale | Class A Common Stock F3, F5, F2 | 17,600 | $142.28 | $2.50M |
| Sale | Class A Common Stock F3, F6, F2 | 5,000 | $143.21 | $716K |
| Sale | Class A Common Stock F3, F7, F2 | 7,694 | $144.24 | $1.11M |
| Sale | Class A Common Stock F3, F8, F2 | 8,003 | $145.26 | $1.16M |
| Sale | Class A Common Stock F3, F9, F2 | 4,601 | $146.15 | $672K |
| Sale | Class A Common Stock F3, F10, F2 | 6,942 | $147.29 | $1.02M |
| Sale | Class A Common Stock F3, F11, F2 | 11,558 | $148.25 | $1.71M |
| Sale | Class A Common Stock F3, F12, F2 | 8,299 | $149.40 | $1.24M |
| Sale | Class A Common Stock F3, F13, F2 | 7,238 | $150.18 | $1.09M |
| Sale | Class A Common Stock F3, F2 | 400 | $150.86 | $60K |
| Sale | Class A Common Stock F3, F14, F2 | 700 | $153.68 | $108K |
| holding | Class A Common Stock F15 | -- | -- | -- |
| holding | Class A Common Stock F16 | -- | -- | -- |
| holding | Class A Common Stock F17 | -- | -- | -- |
Footnotes (17)
- F1. The reported gift was made to The Colgrove Family Charitable Remainder Trust.
- F2. Shares are held by The Colgrove Family Charitable Remainder Trust.
- F3. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on behalf of the applicable trust on January 8, 2026.
- F4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.72 to $141.71 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.74 to $142.72 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.74 to $143.70 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.74 to $144.73 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F8. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.74 to $145.73 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F9. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.74 to $146.70 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F10. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.79 to $147.78 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F11. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.79 to $148.78 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F12. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.79 to $149.72 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F13. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.79 to $150.77 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F14. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.54 to $154.04 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F15. Shares are held by Colgrove Family Living Trust.
- F16. Shares are held by The EEC Irrevocable Trust. A member of the Reporting Person's immediate family is a beneficiary of the trust.
- F17. Shares are held by The RWC Irrevocable Trust. A member of the Reporting Person's immediate family is a beneficiary of the trust.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
Bona fide gift financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.